ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,958Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 617

$537K Total Retail Price of All Prescriptions

Rank: 76 out of 617

478 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,929 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 473 394 1 1
FUROSEMIDE 400 379 2 4
OMEPRAZOLE 399 352 3 3
SIMVASTATIN 317 262 4 2
ATORVASTATIN CALCIUM 273 247 5 14
TRAMADOL HCL 238 204 6 15
HYDROCODONE-ACETAMINOPHEN 226 197 S3 7 8
CITALOPRAM HBR 223 215 8 18
POTASSIUM CHLORIDE 216 199 9 10
METOPROLOL SUCCINATE 215 201 10 12
LOSARTAN POTASSIUM 206 206 11 22
CARVEDILOL 202 202 12 19
CRESTOR 195 186 13 28
METFORMIN HCL 194 157 14 9
LISINOPRIL 180 160 15 5
AMLODIPINE BESYLATE 180 179 15 6
WARFARIN SODIUM 179 167 17 7
BENAZEPRIL HCL 177 167 18 44
HYDROCHLOROTHIAZIDE 157 157 19 13
NAMENDA 128 128 20 35
ZOLPIDEM TARTRATE 113 110 21 23
METOPROLOL TARTRATE 113 113 21 11
ALENDRONATE SODIUM 112 110 23 25
PREDNISONE 110 103 24 31
PANTOPRAZOLE SODIUM 108 106 25 37
LOSARTAN-HYDROCHLOROTHIAZIDE 105 98 26 46
ALLOPURINOL 103 71 27 27
TAMSULOSIN HCL 102 90 28 26
GLIMEPIRIDE 101 98 29 33
POLYETHYLENE GLYCOL 3350 98 64 30 32
FINASTERIDE 98 79 30 104
LEVOFLOXACIN 82 74 32 89
ATENOLOL 81 81 33 17
SPIRIVA 81 76 33 61
ISOSORBIDE MONONITRATE ER 80 63 35 52
CIPROFLOXACIN HCL 77 74 36 60
OXYBUTYNIN CHLORIDE 76 71 37 88
TRIAMTERENE-HCTZ 74 69 38 47
AVODART 73 73 39 144
SPIRONOLACTONE 72 72 40 42
PAROXETINE HCL 71 58 41 62
AMITRIPTYLINE HCL 69 68 R 42 56
BYSTOLIC 68 68 43 64
ZETIA 67 62 44 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 62 45 29
DILTIAZEM ER 58 58 46 81
LANTUS 58 53 46 39
GABAPENTIN 58 51 46 16
ESCITALOPRAM OXALATE 56 46 49 65
DONEPEZIL HCL 54 54 50 30
FENOFIBRATE 52 43 51 58
DILTIAZEM 24HR CD 52 52 51 117
METFORMIN HCL ER 50 48 53 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.